198 related articles for article (PubMed ID: 23212563)
1. Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.
Cisternino S; Chapy H; André P; Smirnova M; Debray M; Scherrmann JM
AAPS J; 2013 Apr; 15(2):299-307. PubMed ID: 23212563
[TBL] [Abstract][Full Text] [Related]
2. Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs.
André P; Debray M; Scherrmann JM; Cisternino S
J Cereb Blood Flow Metab; 2009 Jul; 29(7):1293-304. PubMed ID: 19458607
[TBL] [Abstract][Full Text] [Related]
3. Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.
Chapy H; Smirnova M; André P; Schlatter J; Chiadmi F; Couraud PO; Scherrmann JM; Declèves X; Cisternino S
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539501
[TBL] [Abstract][Full Text] [Related]
4. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
5. A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.
Chapy H; André P; Declèves X; Scherrmann JM; Cisternino S
Br J Pharmacol; 2015 Oct; 172(19):4714-25. PubMed ID: 26177775
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
7. Diphenhydramine as a selective probe to study H
Auvity S; Chapy H; Goutal S; Caillé F; Hosten B; Smirnova M; Declèves X; Tournier N; Cisternino S
J Cereb Blood Flow Metab; 2017 Jun; 37(6):2185-2195. PubMed ID: 27488910
[TBL] [Abstract][Full Text] [Related]
8. How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
Sachkova A; Doetsch DA; Jensen O; Brockmöller J; Ansari S
Biochem Pharmacol; 2021 Oct; 192():114751. PubMed ID: 34464621
[TBL] [Abstract][Full Text] [Related]
9. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.
Chapy H; Saubaméa B; Tournier N; Bourasset F; Behar-Cohen F; Declèves X; Scherrmann JM; Cisternino S
Br J Pharmacol; 2016 Feb; 173(3):497-510. PubMed ID: 26507673
[TBL] [Abstract][Full Text] [Related]
11. Memantine transport across the mouse blood-brain barrier is mediated by a cationic influx H+ antiporter.
Mehta DC; Short JL; Nicolazzo JA
Mol Pharm; 2013 Dec; 10(12):4491-8. PubMed ID: 24098999
[TBL] [Abstract][Full Text] [Related]
12. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
[TBL] [Abstract][Full Text] [Related]
13. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
14. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
[TBL] [Abstract][Full Text] [Related]
15. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
[TBL] [Abstract][Full Text] [Related]
16. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
17. Pyrilamine-sensitive proton-coupled organic cation (H
Wang X; Qi B; Su H; Li J; Sun X; He Q; Fu Y; Zhang Z
J Control Release; 2017 May; 254():34-43. PubMed ID: 28351667
[TBL] [Abstract][Full Text] [Related]
18. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
[TBL] [Abstract][Full Text] [Related]
19. Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB).
Sekhar GN; Georgian AR; Sanderson L; Vizcay-Barrena G; Brown RC; Muresan P; Fleck RA; Thomas SA
PLoS One; 2017; 12(3):e0173474. PubMed ID: 28362799
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
